Impact of Mode of Anesthesia on Ischemia Modified Albumin in Patients With Traumatic Brain Injury

A

Abd-elrahman hassan abd -elaziz

Status

Unknown

Conditions

Oxidative Stress

Study type

Observational

Funder types

Other

Identifiers

NCT04490122
374

Details and patient eligibility

About

In the current study the investigators intend to evaluate the mode of anesthesia on ischemia modified albumin and outcome in patients with traumatic brain injury undergoing emergency craniotomy

Full description

After obtaining Institutional Ethical Committee approval and written informed consent from legally acceptable representative relatives, patients with traumatic brain injury, aged from 18- 60 years old, ASA from (I-III), GCS more than 8 undergoing emergency craniotomy surgery will be selected for this prospective randomized Study. The anesthesia will be induced with 2mcg/kg fentanyl and 2 mg/kg propofol. Muscle relaxation will be achieved with 0.5 mg/kg atracurium. Anesthesia will be maintained with: Group I, isoflurane (mac<1) mixed with oxygen 40% and fentanyl 1mcg/kg hourly. Group PD, propofol infusion(100-150mcg/kg/min) and dexmedetomedine 0.3mcg/kg /h. Parameters will be assessed Preoperative period Ischemia modified albumin level from venous sample. Basal Systolic blood pressure, diastolic blood pressure. Mean arterial blood pressure, oxygen saturation, heart rate. GCS. Intraoperative period Systolic blood pressure, diastolic blood pressure. Mean arterial blood pressure, oxygen saturation, heart rate after intubation, 5,15,30,60,90min and after extubation. Need for resuscitation with vasoactive drugs. Brain relaxation score at dural opening and closure. ICP Intraoperative blood loss. Amount of fluid and blood transfusion. Postoperative period Ischemia modified albumin immediately postoperatively, after 6h and after 24 hours. Type of surgery. Duration of surgery. Extubation time. Recovery scores (Ramsay sedation score and modified Alderte score). GCS immediately postoperatively, after 6h, after 24h and after 48 hours. Total analgesic requirement during the first 24 hours. Need for ICU admission. Length of ICU stay. Complications. 28 day mortality.

Enrollment

54 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-60 years old of both sex .
  • Isolated traumatic brain injury undergoing emergency craniotomy.
  • G.C.S more than 8.
  • ASA grade (I-III).

Exclusion criteria

  • Non traumatic brain injury.
  • Poly trauma patient.
  • Coagulation disorder.
  • Drug( alcohol, opiods, tranquilizers) addiction.
  • Liver and kidney dysfunction.
  • Severe diseases such as severe hypertension, cardiovascular disease, malignant tumor, autoimmune disease, mental disorders.
  • Diabetes mellitus with poor blood glucose control.
  • Previous drug allergy.
  • Currently lactating.

Trial design

54 participants in 2 patient groups

Inhalational
Description:
will receive inhalational anesthesia
Total intravenous
Description:
will receive total intravenous anesthesia with propofol infusion(100-150 mcg/kg/min) and dexmedetomedine 0.3mcg/kg/h.

Trial contacts and locations

0

Loading...

Central trial contact

Abdel-rahman Abdel-aziz

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems